Last reviewed · How we verify
Candesartan and enalapril
Candesartan and enalapril is a Small molecule drug developed by Herlev Hospital. It is currently FDA-approved.
At a glance
| Generic name | Candesartan and enalapril |
|---|---|
| Sponsor | Herlev Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The COVID-RASi Trial (COVID-19) (PHASE3)
- Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
- An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan
- Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction (PHASE4)
- Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
- Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (PHASE3)
- Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Candesartan and enalapril CI brief — competitive landscape report
- Candesartan and enalapril updates RSS · CI watch RSS
- Herlev Hospital portfolio CI
Frequently asked questions about Candesartan and enalapril
What is Candesartan and enalapril?
Candesartan and enalapril is a Small molecule drug developed by Herlev Hospital.
Who makes Candesartan and enalapril?
Candesartan and enalapril is developed and marketed by Herlev Hospital (see full Herlev Hospital pipeline at /company/herlev-hospital).
What development phase is Candesartan and enalapril in?
Candesartan and enalapril is FDA-approved (marketed).
Related
- Manufacturer: Herlev Hospital — full pipeline
- Compare: Candesartan and enalapril vs similar drugs
- Pricing: Candesartan and enalapril cost, discount & access